|Bid||115.80 x 0|
|Ask||115.82 x 0|
|Day's range||115.26 - 116.32|
|52-week range||95.00 - 116.32|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||26.99|
|Earnings date||29 Jul 2021|
|Forward dividend & yield||2.75 (2.55%)|
|Ex-dividend date||19 Apr 2021|
|1y target est||87.75|
(Bloomberg) -- The U.S. Supreme Court gave companies a broader shield against lawsuits by victims of overseas atrocities, rejecting accusations that Nestle SA’s U.S. unit and Cargill Inc. were complicit in the use of child slavery on Ivory Coast cocoa farms.The justices said the allegations against the companies lacked enough of a U.S. connection to go forward under the 1789 Alien Tort Statute.The court stopped short of exempting corporations from liability under the law altogether. But lawyers
The U.S. Supreme Court on Thursday threw out a lawsuit accusing Cargill Inc and a Nestle SA subsidiary of knowingly helping perpetuate slavery at Ivory Coast cocoa farms, but sidestepped a broader ruling on the permissibility of suits accusing American companies of human rights violations abroad. The 8-1 ruling authored by Justice Clarence Thomas reversed a lower court decision that had allowed the lawsuit, brought on behalf of former child slaves from Mali who worked at the farms, filed against the companies in 2005 to proceed. The court ruled the claim could not be brought under the Alien Tort Statute, which lets non-U.S. citizens seek damages in American courts in certain instances, because the plaintiffs did not show that any of the relevant conduct took place within the United States.
Nestle said on Monday it was working on updating its nutrition and health strategy after the Financial Times reported an internal document at the food giant described a large portion of its food and drinks as unhealthy. The newspaper said it had seen an internal presentation circulated among top executives early this year stating that more than 60% of Nestle's mainstream food and drinks portfolio could not be considered healthy under a "recognised definition of health". The paper said this assessment applied to about half of Nestle's overall portfolio because categories like medical nutrition, pet food, coffee and infant formula were excluded from the analysis.